The United States Preventive Services Task Force PSA Screening Recommendations- David Penson
Video Player is loading.
July 31, 2018
(Length of Discussion: 10 min)
David Penson and Alicia Morgans share views on the evolution of the United States Preventive Services Task Force, USPSTF's recommendations for PSA screening. What do the recent changes mean to the clinician and the patient when making individual decisions regarding screening.
Biographies:
David F. Penson, MD, MPH, is the Paul V. Hamilton, M.D. and Virginia E. Howd Chair in Urologic Oncology and Professor of Urologic Surgery and Medicine at Vanderbilt University Medical Center and the director of the Center for Surgical Quality and Outcomes Research in the Vanderbilt Institute for Medicine and Public Health.
Alicia Morgans, MD, MPH
David Penson and Alicia Morgans share views on the evolution of the United States Preventive Services Task Force, USPSTF's recommendations for PSA screening. What do the recent changes mean to the clinician and the patient when making individual decisions regarding screening.
Biographies:
David F. Penson, MD, MPH, is the Paul V. Hamilton, M.D. and Virginia E. Howd Chair in Urologic Oncology and Professor of Urologic Surgery and Medicine at Vanderbilt University Medical Center and the director of the Center for Surgical Quality and Outcomes Research in the Vanderbilt Institute for Medicine and Public Health.
Alicia Morgans, MD, MPH
Referenced in this discussion:
The Impact of PLCO control arm contamination on perceived PSA screening
ERSPC Trial
The Impact of PLCO control arm contamination on perceived PSA screening
ERSPC Trial